Skip Navigation

Masks are required inside all of our care facilities. We are vaccinating all eligible patients. Learn more:

Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus

Find more COVID-19 testing locations on Maryland.gov.

Find a Doctor

Find a Researcher

Katherine Meryl Bever, M.D.

Katherine Meryl Bever, M.D.

Headshot of Katherine Meryl Bever
  • Assistant Professor of Oncology
Female

Expertise

Oncology

Request an Appointment

Insurance Information

Existing Patients

Request your next appointment through MyChart

Main Phone

410-955-8964

Outside of Maryland & Washington D.C.

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital

Appointment Phone: 410-955-8964
600 N. Wolfe Street
Baltimore, MD 21287 map

Background

Dr. Katherine Bever is a medical oncologist in Baltimore, caring for patients with gastrointestinal malignancies, including gastric, pancreatic, colorectal, neuroendocrine and biliary cancers.

Dr. Bever received her undergraduate degree in biophysics from Johns Hopkins University. She earned her M.D. from the University of Maryland School of Medicine. She completed her residency in internal medicine at Boston University School of Medicine and performed a fellowship in medical oncology at Johns Hopkins. Dr. Bever joined the Johns Hopkins faculty in 2015.

Prior to joining Johns Hopkins, Dr. Bever was an internist at the Amyloidosis Center at Boston University School of Medicine.

Dr. Bever was recognized with a Pearl M. Stetler Fellowship Award in 2018. She is a member of several professional organizations, including the Society for Immunotherapy of Cancer, the American Association of Clinical Research and the American Society of Clinical Oncology.

...read more

Titles

  • Assistant Professor of Oncology

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; University of Maryland School of Medicine (2011)

Residencies

  • Internal Medicine; Boston Medical Center (2014)

Fellowships

  • Oncology; Johns Hopkins University School of Medicine (2018)

Board Certifications

  • American Board of Internal Medicine (Internal Medicine) (2014)
  • American Board of Internal Medicine (Medical Oncology) (2017)

Research & Publications

Research Summary

Dr. Bever’s research focuses on understanding tumor susceptibility to and mechanisms of resistance to immunotherapy through clinical and translational investigations in gastrointestinal cancers. She is also interested in developing strategies to overcome immunotherapy resistance through rationally selected combinations.

Clinical Trials

Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma

Selected Publications

Pudusseri A, Sanchorawala V, Sloan JM, Bever KM, Doros G, Kataria S, Sarosiek S. “Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis.” Am J Hematol. 2019 Oct;94(10):1098-1103

Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Azad NS, Rucki AA, Laheru D, Donehower R, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Greten TF, Duffy AG, Ciombor KK, Eyring AD, Lam BH, Joe A, Kang SP, Holdhoff M, Danilova L, Cope L, Meyer C, Zhou S, Goldberg RM, Armstrong DK, Bever KM, Fader AN, Taube J, Housseau F, Spetzler D, Xiao N, Pardoll DM, Papadopoulos N, Kinzler KW, Eshleman JR, Vogelstein B, Anders RA, Diaz LA Jr. “Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade.” Science. 2017;357(6349):409‐413

Bever KM, Masha LI, Sun F, Stern L, Havasi A, Berk JL, Sanchorawala V, Seldin DC, Sloan JM. “Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis.” Haematologica. 2016;101(1):86-90

Bever KM, Sugar EA, Bigelow E, Sharma R, Laheru D, Wolfgang CL, Jaffee EM, Anders RA, De Jesus-Acosta A, Zheng L. “The prognostic value of stroma in pancreatic cancer for patients receiving adjuvant therapy.” HPB (Oxford). 2015;17(4):292-8

Cosgrove MS, Bever K, Avalos JL, Muhammad S, Zhang X, Wolberger C. “The structural basis of sirtuin substrate affinity.” Biochemistry. 2006;45(24):7511-21

Activities & Honors

Honors

  • Pearl M. Stetler Fellowship Award, Johns Hopkins, 2018
  • Translational Cancer Research Award, Swim Across America, 2017
  • First Place, Senior Resident Academic Day Poster Session, Boston University School of Medicine, 2014
  • Selected as “Mini-Chief,” Internal Medicine Residency Program, Boston University School of Medicine, 2013
  • Resident Teaching Award, Boston University School of Medicine, 2013
  • Medical Student Abstract Competition Winner, American College of Physicians Annual Meeting, 2010
  • First Place, Graduate Student Category, Department of Surgery Poster Session, Johns Hopkins University, 2010

Memberships

  • Society for Immunotherapy of Cancer, 2018
  • American Association of Clinical Research, 2016
  • American Society of Clinical Oncology, 2015
  • American Society of Hematology, 2015

Videos & Media

Lectures and Presentations

  • Morbidity and Mortality Oncology Grand Rounds
    Lecture (10/01/2017)
    Johns Hopkins Hospital
Is this you? Edit Profile
back to top button